Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vacuolar-type H+-ATPase (V-ATPase) is a highly conserved, multi-subunit enzyme complex that functions as an ATP-driven proton pump, primarily responsible for the acidification of intracellular compartments such as lysosomes, endosomes, and the Golgi apparatus [UniProt P27449]. The Vo c-subunit is a fundamental component of the membrane-integral Vo domain, where it forms a proteolipid ring that rotates to translocate protons across the lipid bilayer [PubMed: 17203062]. This acidification is essential for diverse biological processes, including the activation of lysosomal hydrolases, receptor-mediated endocytosis, and the coupled transport of neurotransmitters [PubMed: 18606446]. In disease states, V-ATPase is often dysregulated; for example, its overexpression on the plasma membrane of cancer cells facilitates an acidic tumor microenvironment that promotes protease activation and metastasis [PubMed: 25613000]. Additionally, it is critical for bone resorption by osteoclasts and serves as a gateway for the entry of various pH-dependent viruses [PubMed: 20530212]. While the c-subunit is a potent target for inhibitors like bafilomycin A1, the ubiquitous necessity of V-ATPase for cellular viability presents significant challenges for achieving therapeutic selectivity and minimizing systemic toxicity [PubMed: 20433182].
Inhibition of the proton-translocating Vo domain by binding to the c-subunit ring, thereby blocking the rotational mechanism required for proton transport across the membrane.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar-type H+-ATPase subunit c (ATP6V0C) (ATP6V0C).